News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sisram, A Fosun Pharma (2196) Device Company, Staging A $200 Million Hong Kong IPO



9/6/2017 12:24:55 PM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Sisram Medical, an Israeli company that makes laser-based aesthetic devices, will raise up to $200 million by conducting an IPO on the Hong Kong Exchange. Sisram is a subsidiary of Shanghai Fosun Pharma. In 2013, Fosun teamed up with Chindex, which would become a Fosun subsidiary, and a private equity firm to pay $240 million for 96% of Israel's Alma Lasers. The holding company is named Sisram. The IPO will value Sisram at up to $800 million, with Fosun owning a 66% stake.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES